Status:
UNKNOWN
Validation of a Process for the Manufacture of Stem Cells Isolated From the Nasal Cavity for Innovative Cell Therapy of Traumatized Peripheral Nerves
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Septoplasty
Turbinoplasty
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Despite progress in the time taken to take charge and in the quality of the surgical technique, the repair of damaged peripheral nerves has not improved in the last twenty years. Faced with these limi...
Eligibility Criteria
Inclusion
- Major adults men or women
- Affiliated to a social security scheme.
- Absence of contraindication to general and / or local anesthesia
- Relevant to an operative indication of functional surgery of the nose (septoplasty and / or turbinoplasty)
Exclusion
- Patients with proven organic pathologies of the nervous system
- Pregnant and / or lactating women
- Persons deprived of their liberty
- Major under guardianship
- persons unable to read the information document.
- Patients with chronic inflammatory and / or infectious rhinosinusitis
- Patient under antithrombotic therapy
- Patient with hypersensitivity to local amide-bound anesthetics (such as lidocaine) or to any of the components, including methyl parahydroxybenzoate contained in the vehicle.
- Patient with porphyria.
- Patient with epilepsy not controlled by treatment.
- Patient with a history of surgery on the ethmoid and / or the average turbinate bilaterally.
- Patient with a history of cervico-cephalic radiotherapy
Key Trial Info
Start Date :
December 10 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 10 2021
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04020367
Start Date
December 10 2018
End Date
August 10 2021
Last Update
July 16 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service d'Oto-Rhino-Laryngologie - Conception - AP-HM
Marseille, France, 13354